Staphylococcus aureus - Xen31 strain生物發(fā)光金黃色葡萄球菌菌株

Infectious disease is a perennially important area for both life science research and drug discovery. Some of the first applications of IVIS? imaging technology were in tracking infections and monitoring host responses, and these applications are still at the forefront of research. PerkinElmer's bioluminescent infectious disease light-producing microorganisms have been developed to mimic both acute and chronic standard infection protocols presently used by researchers. Engineered Bacterium: Staphylococcus aureus - Xen31 Parental Strain: American Type Culture Collection, used under license In Vitro/Ex Vivo: Growth and Antibiogram profiles, Biofilm In Vivo: Sepsis, Soft tissue, and Biofilm models Advantages of using bioluminescent light-producing microorganisms for drug discovery in vitro: Rapid and readily amenable to high throughput screening, e.g., 96 or 384-well format Sensitivity - subtle changes in cellular viability are rapidly detected Inexpensive - no additional substrates needed for bacterial assays Advantages of using bioluminescent light-producing microorganisms for drug discovery in vivo: Rapid identification of lead drug candidates Real-time efficacy data May help to decrease drug failure by allowing disease relapse to be monitored in the same animal

Supplier來源:BioVector NTCC Inc.
TEL電話:+86-010-53513060
Website網(wǎng)址: http://www.nedfriskphoto.com